Petter Veiby
Förmögenhet: 2 M $ per 2026-08-31
Förmögenhet: 2 M $ per 2026-08-31
Mr. Petter Veiby is a Chief Scientific Officer at Attovia Therapeutics, Inc. He is on the Board of Directors at BiVictriX Therapeutics Plc.
Mr. Veiby was previously employed as a Senior Director by Takeda Oncology Co., a Senior Vice President-Business Development by Immunitas Therapeutics, Inc., a Head-Alliances by Zai Lab Ltd., and a Global Head-Biotherapeutics by Takeda Oncology Co.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-08-05 | 104 952 ( 0,23 % ) | 2 M $ | 2026-08-31 |
| Företag | Position | Start |
|---|---|---|
| ATTOVIA THERAPEUTICS, INC. | Grundare | 2022-12-16 |
| BIVICTRIX THERAPEUTICS PLC | Direktör/Styrelseledamot | 2025-08-01 |
| Företag | Position | Slut |
|---|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Direktör/Styrelseledamot | 2023-06-01 |
Immunitas Therapeutics, Inc.
Immunitas Therapeutics, Inc. BiotechnologyHealth Technology Develops single cell genomic-based drugs | Företagsledare/Principal | 2022-11-01 |
| ZAI LAB LIMITED | Företagsledare/Principal | 2022-05-01 |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Företagsledare/Principal | 2020-03-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 5 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
Zai Lab Ltd.
Zai Lab Ltd. BiotechnologyHealth Technology Develops medicine for cancer, autoimmune and infectious diseases | Health Technology |
BiVictriX Therapeutics Plc
BiVictriX Therapeutics Plc Pharmaceuticals: MajorHealth Technology Develops and distributes cancer therapeutics | Health Technology |
Immunitas Therapeutics, Inc.
Immunitas Therapeutics, Inc. BiotechnologyHealth Technology Develops single cell genomic-based drugs | Health Technology |
Attovia Therapeutics
Attovia Therapeutics BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that researches & develops therapeutic products in the fields of immune-mediated diseases | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån